5 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
#anticoagulation ... #clotting #INR ... #heparin #LMWH # ... NOAC #warfarin # ... #pharmacology #
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Heparin, Fondaparinux ... the mainstay of VTE ... #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... #anticoagulation ... #pharmacology # ... medications #doac
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
filtration rate; DOAC ... anticoagulant; LMWH ... molecular weight heparin ... #DOAC #VTE #Malignancy ... #Management #Hematology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
: • Initial heparin ... (rivaroxaban, apixaban ... , edoxaban) • Warfarin ... : therapeutic INR ... #management #cardiology